Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy : Review proposal paper
Cited by National Institute for Health and Care Excellence on
The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.